Methotrexate Provokes Disparate Folate Metabolism Gene Expression and Alternative Splicing in Ex Vivo Monocytes and GM-CSF- and M-CSF-Polarized Macrophages

Macrophages constitute important immune cell targets of the antifolate methotrexate (MTX) in autoimmune diseases, including rheumatoid arthritis. Regulation of folate/MTX metabolism remains poorly understood upon pro-inflammatory (M1-type/GM-CSF-polarized) and anti-inflammatory (M2-type/M-CSF-polarized) macrophages. MTX activity strictly relies on the folylpolyglutamate synthetase (FPGS) dependent intracellular conversion and hence retention to MTX-polyglutamate (MTX-PG) forms. Here, we determined FPGS pre-mRNA splicing, FPGS enzyme activity and MTX-polyglutamylation in human monocyte-derived M1- and M2-macrophages exposed to 50 nmol/L MTX ex vivo. Moreover, RNA-sequencing analysis was used to investigate global splicing profiles and differential gene expression in monocytic and MTX-exposed macrophages. Monocytes displayed six–eight-fold higher ratios of alternatively-spliced/wild type FPGS transcripts than M1- and M2-macrophages. These ratios were inversely associated with a six–ten-fold increase in FPGS activity in M1- and M2-macrophages versus monocytes. Total MTX-PG accumulation was four-fold higher in M1- versus M2-macrophages. Differential splicing after MTX-exposure was particularly apparent in M2-macrophages for histone methylation/modification genes. MTX predominantly induced differential gene expression in M1-macrophages, involving folate metabolic pathway genes, signaling pathways, chemokines/cytokines and energy metabolism. Collectively, macrophage polarization-related differences in folate/MTX metabolism and downstream pathways at the level of pre-mRNA splicing and gene expression may account for variable accumulation of MTX-PGs, hence possibly impacting MTX treatment efficacy.

[1]  S. Jia,et al.  Macrophage: Key player in the pathogenesis of autoimmune diseases , 2023, Frontiers in Immunology.

[2]  W. Lems,et al.  Pharmacokinetics of oral and subcutaneous methotrexate in red and white blood cells in patients with early rheumatoid arthritis: the methotrexate monitoring trial , 2022, Annals of the rheumatic diseases.

[3]  A. Devitt,et al.  Macrophages: The Good, the Bad, and the Gluttony , 2021, Frontiers in Immunology.

[4]  Steven van Dijk,et al.  Computational comparison of common event-based differential splicing tools: practical considerations for laboratory researchers , 2021, BMC Bioinformatics.

[5]  M. Miranda-Carús,et al.  The Macrophage Reprogramming Ability of Antifolates Reveals Soluble CD14 as a Potential Biomarker for Methotrexate Response in Rheumatoid Arthritis , 2021, bioRxiv.

[6]  G. Berry,et al.  Metabolic Control of Autoimmunity and Tissue Inflammation in Rheumatoid Arthritis , 2021, Frontiers in Immunology.

[7]  Y. Assaraf,et al.  Folylpoly-ɣ-glutamate synthetase association to the cytoskeleton: Implications to folate metabolon compartmentalization. , 2021, Journal of proteomics.

[8]  James C. Wright,et al.  GENCODE 2021 , 2020, Nucleic Acids Res..

[9]  G. Jansen,et al.  Identification of Metabolic Biomarkers in Relation to Methotrexate Response in Early Rheumatoid Arthritis , 2020, Journal of personalized medicine.

[10]  Nadezhda T. Doncheva,et al.  The STRING database in 2021: customizable protein–protein networks, and functional characterization of user-uploaded gene/measurement sets , 2020, Nucleic Acids Res..

[11]  Maxim N. Artyomov,et al.  Immunometabolism in the Single-Cell Era. , 2020, Cell metabolism.

[12]  E. Giovannetti,et al.  The role of alternative splicing in cancer: From oncogenesis to drug resistance. , 2020, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[13]  W. Lems,et al.  Association of altered folylpolyglutamate synthetase pre-mRNA splicing with methotrexate unresponsiveness in early rheumatoid arthritis , 2020, Rheumatology.

[14]  L. Matherly,et al.  Therapeutic Targeting of Mitochondrial One-Carbon Metabolism in Cancer , 2020, Molecular Cancer Therapeutics.

[15]  H. D. de Vries,et al.  Succinate Is an Inflammation-Induced Immunoregulatory Metabolite in Macrophages , 2020, Metabolites.

[16]  R. Pieters,et al.  Correction: Patient-derived oral mucosa organoids as an in vitro model for methotrexate induced toxicity in pediatric acute lymphoblastic leukemia , 2020, PloS one.

[17]  G. Peters,et al.  Expression profiling of ABC transporters in peripheral blood lymphocytes and monocyte-derived macrophages of rheumatoid arthritis patients , 2020 .

[18]  M. Barrett,et al.  Changes in Plasma Itaconate Elevation in Early Rheumatoid Arthritis Patients Elucidates Disease Activity Associated Macrophage Activation , 2020, Metabolites.

[19]  R. Pieters,et al.  Patient-derived oral mucosa organoids as an in vitro model for methotrexate induced toxicity in pediatric acute lymphoblastic leukemia , 2020, PloS one.

[20]  E. Giovannetti,et al.  Glucocorticoid Resistant Pediatric Acute Lymphoblastic Leukemia Samples Display Altered Splicing Profile and Vulnerability to Spliceosome Modulation , 2020, Cancers.

[21]  T. Aune,et al.  Methotrexate and its mechanisms of action in inflammatory arthritis , 2020, Nature Reviews Rheumatology.

[22]  C. Corciulo,et al.  Signaling of the Purinergic System in the Joint , 2020, Frontiers in Pharmacology.

[23]  L. Matherly,et al.  Cellular Pharmacodynamics of a Novel Pyrrolo[3,2-d]pyrimidine Inhibitor Targeting Mitochondrial and Cytosolic One-Carbon Metabolism , 2019, Molecular Pharmacology.

[24]  W. Lems,et al.  Development and validation of a sensitive UHPLC-MS/MS-based method for the analysis of folylpolyglutamate synthetase enzymatic activity in peripheral blood mononuclear cells: application in rheumatoid arthritis and leukemia patients. , 2019, Therapeutic drug monitoring.

[25]  Yingliang Wu,et al.  One-Carbon Metabolism Supports S-Adenosylmethionine and Histone Methylation to Drive Inflammatory Macrophages. , 2019, Molecular cell.

[26]  A. Viola,et al.  The Metabolic Signature of Macrophage Responses , 2019, Front. Immunol..

[27]  J. Rabinowitz,et al.  Serine Metabolism Supports Macrophage IL-1β Production. , 2019, Cell metabolism.

[28]  P. Low,et al.  Folate receptors and transporters: biological role and diagnostic/therapeutic targets in cancer and other diseases , 2019, Journal of experimental & clinical cancer research : CR.

[29]  N. Lee,et al.  Aberrant RNA Splicing in Cancer and Drug Resistance , 2018, Cancers.

[30]  J. Blenis,et al.  Mitochondrial One-Carbon Pathway Supports Cytosolic Folate Integrity in Cancer Cells , 2018, Cell.

[31]  B. Ryffel,et al.  Succinate receptor deficiency attenuates arthritis by reducing dendritic cell traffic and expansion of Th17 cells in the lymph nodes , 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  P. Low,et al.  Prophylactic and therapeutic activity of alkaline phosphatase in arthritic rats: single‐agent effects of alkaline phosphatase and synergistic effects in combination with methotrexate , 2018, Translational research : the journal of laboratory and clinical medicine.

[33]  Cristina Municio,et al.  Methotrexate limits inflammation through an A20-dependent cross-tolerance mechanism , 2018, Annals of the rheumatic diseases.

[34]  F. Di Virgilio,et al.  The P2X7 Receptor in Infection and Inflammation , 2017, Immunity.

[35]  Joshua D Rabinowitz,et al.  One-Carbon Metabolism in Health and Disease. , 2017, Cell metabolism.

[36]  J. Isaacs,et al.  Mechanism of action of methotrexate in rheumatoid arthritis, and the search for biomarkers , 2016, Nature Reviews Rheumatology.

[37]  I. McInnes,et al.  Rheumatoid arthritis , 2016, The Lancet.

[38]  T. Nanki,et al.  Folylpolyglutamate synthase is a major determinant of intracellular methotrexate polyglutamates in patients with rheumatoid arthritis , 2016, Scientific Reports.

[39]  Y. Assaraf,et al.  Folylpoly-γ-glutamate synthetase: A key determinant of folate homeostasis and antifolate resistance in cancer. , 2016, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[40]  T. Junt,et al.  GPR91 senses extracellular succinate released from inflammatory macrophages and exacerbates rheumatoid arthritis , 2016, The Journal of experimental medicine.

[41]  A. Mantovani,et al.  Macrophage heterogeneity in the context of rheumatoid arthritis , 2016, Nature Reviews Rheumatology.

[42]  G. Peters,et al.  Folylpolyglutamate synthetase splicing alterations in acute lymphoblastic leukemia are provoked by methotrexate and other chemotherapeutics and mediate chemoresistance , 2016, International journal of cancer.

[43]  G. Peters,et al.  The association of aberrant folylpolyglutamate synthetase splicing with ex vivo methotrexate resistance and clinical outcome in childhood acute lymphoblastic leukemia , 2016, Haematologica.

[44]  A. Dopazo,et al.  Methotrexate selectively targets human proinflammatory macrophages through a thymidylate synthase/p53 axis , 2016, Annals of the rheumatic diseases.

[45]  F. Liew,et al.  Low expression of CD39 on regulatory T cells as a biomarker for resistance to methotrexate therapy in rheumatoid arthritis , 2015, Proceedings of the National Academy of Sciences.

[46]  Cristina Municio,et al.  Macrophages from the synovium of active rheumatoid arthritis exhibit an activin A‐dependent pro‐inflammatory profile , 2015, The Journal of pathology.

[47]  I. Sanz,et al.  The number of circulating monocytes as biomarkers of the clinical response to methotrexate in untreated patients with rheumatoid arthritis , 2015, Journal of Translational Medicine.

[48]  Lan Lin,et al.  rMATS: Robust and flexible detection of differential alternative splicing from replicate RNA-Seq data , 2014, Proceedings of the National Academy of Sciences.

[49]  Shirley M. Taylor,et al.  Mammalian Mitochondrial and Cytosolic Folylpolyglutamate Synthetase Maintain the Subcellular Compartmentalization of Folates* , 2014, The Journal of Biological Chemistry.

[50]  Björn Usadel,et al.  Trimmomatic: a flexible trimmer for Illumina sequence data , 2014, Bioinform..

[51]  B. Dijkmans,et al.  Methotrexate analogues display enhanced inhibition of TNF-α production in whole blood from RA patients , 2014, Scandinavian journal of rheumatology.

[52]  W. Lems,et al.  Methotrexate normalizes up-regulated folate pathway genes in rheumatoid arthritis. , 2013, Arthritis and rheumatism.

[53]  D. van Zeben,et al.  Association of low baseline levels of erythrocyte folate with treatment nonresponse at three months in rheumatoid arthritis patients receiving methotrexate. , 2013, Arthritis and rheumatism.

[54]  Yehuda G Assaraf,et al.  Antifolates in cancer therapy: structure, activity and mechanisms of drug resistance. , 2012, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[55]  R. Moran,et al.  Tetrahydrofolate Recognition by the Mitochondrial Folate Transporter* , 2011, The Journal of Biological Chemistry.

[56]  D. Appling,et al.  Compartmentalization of Mammalian folate-mediated one-carbon metabolism. , 2010, Annual review of nutrition.

[57]  R. Gaedigk,et al.  Analysis of intracellular methotrexate polyglutamates in patients with juvenile idiopathic arthritis: effect of route of administration on variability in intracellular methotrexate polyglutamate concentrations. , 2010, Arthritis and rheumatism.

[58]  A. Puig-Kröger,et al.  Folate receptor beta is expressed by tumor-associated macrophages and constitutes a marker for M2 anti-inflammatory/regulatory macrophages. , 2009, Cancer research.

[59]  Mark D. Robinson,et al.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..

[60]  G. Jansen,et al.  ABC drug transporters and immunity: novel therapeutic targets in autoimmunity and cancer , 2009, Journal of leukocyte biology.

[61]  F. Glaser,et al.  Hereditary folate malabsorption: a positively charged amino acid at position 113 of the proton-coupled folate transporter (PCFT/SLC46A1) is required for folic acid binding. , 2009, Biochemical and biophysical research communications.

[62]  P. Tak,et al.  The dynamics of macrophage lineage populations in inflammatory and autoimmune diseases. , 2009, Arthritis and rheumatism.

[63]  Y. Assaraf,et al.  Aberrant splicing of folylpolyglutamate synthetase as a novel mechanism of antifolate resistance in leukemia. , 2009, Blood.

[64]  B. Dijkmans,et al.  Involvement of breast cancer resistance protein expression on rheumatoid arthritis synovial tissue macrophages in resistance to methotrexate and leflunomide. , 2009, Arthritis and rheumatism.

[65]  L. Matherly,et al.  Membrane transporters and folate homeostasis: intestinal absorption and transport into systemic compartments and tissues , 2009, Expert Reviews in Molecular Medicine.

[66]  F. Glaser,et al.  A novel loss-of-function mutation in the proton-coupled folate transporter from a patient with hereditary folate malabsorption reveals that Arg 113 is crucial for function. , 2008, Blood.

[67]  Y. Assaraf.  The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis. , 2006, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[68]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[69]  G. Peters,et al.  ABCG2 harboring the Gly482 mutation confers high-level resistance to various hydrophilic antifolates. , 2005, Cancer research.

[70]  Yehuda G. Assaraf,et al.  Folate Deprivation Results in the Loss of Breast Cancer Resistance Protein (BCRP/ABCG2) Expression , 2004, Journal of Biological Chemistry.

[71]  Y. Assaraf,et al.  Antifolate resistance associated with loss of MRP1 expression and function in Chinese hamster ovary cells with markedly impaired export of folate and cholate. , 2003, Molecular pharmacology.

[72]  G. Peters,et al.  Loss of Multidrug Resistance Protein 1 Expression and Folate Efflux Activity Results in a Highly Concentrative Folate Transport in Human Leukemia Cells* , 2003, The Journal of Biological Chemistry.

[73]  Y. Assaraf,et al.  Loss of folylpoly‐γ‐glutamate synthetase activity is a dominant mechanism of resistance to polyglutamylation‐dependent novel antifolates in multiple human leukemia sublines , 2003, International journal of cancer.

[74]  G. Peters,et al.  Multiple mechanisms of resistance to methotrexate and novel antifolates in human CCRF-CEM leukemia cells and their implications for folate homeostasis. , 2002, Biochemical pharmacology.

[75]  R. Straub,et al.  Anti-inflammatory mechanisms of methotrexate in rheumatoid arthritis , 2001, Annals of the rheumatic diseases.

[76]  T. Nakamura,et al.  Selective expression of folate receptor beta and its possible role in methotrexate transport in synovial macrophages from patients with rheumatoid arthritis. , 1999, Arthritis and rheumatism.

[77]  G. Peters,et al.  Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2. , 1999, Cancer research.

[78]  M. Rots,et al.  Role of folylpolyglutamate synthetase and folylpolyglutamate hydrolase in methotrexate accumulation and polyglutamylation in childhood leukemia. , 1999, Blood.

[79]  J. Barredo,et al.  Determinants of antifolate cytotoxicity: folylpolyglutamate synthetase activity during cellular proliferation and development. , 1992, Molecular pharmacology.

[80]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[81]  B. Dijkmans,et al.  Folate receptor beta as a potential delivery route for novel folate antagonists to macrophages in the synovial tissue of rheumatoid arthritis patients. , 2009, Arthritis and rheumatism.

[82]  Alex E. Lash,et al.  Gene Expression Omnibus: NCBI gene expression and hybridization array data repository , 2002, Nucleic Acids Res..